Annual Cash & Cash Equivalents
$979.00 K
-$4.81 M-83.10%
December 31, 2023
Summary
- As of February 8, 2025, ICCC annual cash & cash equivalents is $979.00 thousand, with the most recent change of -$4.81 million (-83.10%) on December 31, 2023.
- During the last 3 years, ICCC annual cash & cash equivalents has fallen by -$5.97 million (-85.91%).
- ICCC annual cash & cash equivalents is now -90.39% below its all-time high of $10.19 million, reached on December 31, 2021.
Performance
ICCC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$3.81 M
+$2.48 M+187.59%
September 30, 2024
Summary
- As of February 8, 2025, ICCC quarterly cash and cash equivalents is $3.81 million, with the most recent change of +$2.48 million (+187.59%) on September 30, 2024.
- Over the past year, ICCC quarterly cash and cash equivalents has increased by +$2.85 million (+296.61%).
- ICCC quarterly cash and cash equivalents is now -67.77% below its all-time high of $11.82 million, reached on March 31, 2022.
Performance
ICCC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ICCC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -83.1% | +296.6% |
| 3 y3 years | -85.9% | +296.6% |
| 5 y5 years | -61.2% | +296.6% |
ICCC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.4% | at low | -67.8% | +296.6% |
| 5 y | 5-year | -90.4% | at low | -67.8% | +296.6% |
| alltime | all time | -90.4% | +63.2% | -67.8% | +1169.5% |
ImmuCell Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.81 M(+187.6%) |
| Jun 2024 | - | $1.32 M(+37.9%) |
| Mar 2024 | - | $960.30 K(-1.9%) |
| Dec 2023 | $979.00 K(-83.1%) | $978.70 K(-50.8%) |
| Sep 2023 | - | $1.99 M(+36.8%) |
| Jun 2023 | - | $1.45 M(-53.0%) |
| Mar 2023 | - | $3.10 M(-46.5%) |
| Dec 2022 | $5.79 M(-43.1%) | $5.79 M(-34.4%) |
| Sep 2022 | - | $8.83 M(-20.1%) |
| Jun 2022 | - | $11.04 M(-6.5%) |
| Mar 2022 | - | $11.82 M(+16.0%) |
| Dec 2021 | $10.19 M(+46.6%) | $10.19 M(-3.0%) |
| Sep 2021 | - | $10.50 M(-1.9%) |
| Jun 2021 | - | $10.70 M(+57.2%) |
| Mar 2021 | - | $6.81 M(-2.1%) |
| Dec 2020 | $6.95 M(+10.4%) | $6.95 M(+77.4%) |
| Sep 2020 | - | $3.92 M(-36.8%) |
| Jun 2020 | - | $6.20 M(-4.6%) |
| Mar 2020 | - | $6.51 M(+3.4%) |
| Dec 2019 | $6.29 M(+149.6%) | $6.29 M(+167.3%) |
| Sep 2019 | - | $2.35 M(+81.7%) |
| Jun 2019 | - | $1.30 M(-87.8%) |
| Mar 2019 | - | $10.58 M(+319.8%) |
| Dec 2018 | $2.52 M(-33.6%) | $2.52 M(+5.3%) |
| Sep 2018 | - | $2.39 M(-4.8%) |
| Jun 2018 | - | $2.51 M(-17.8%) |
| Mar 2018 | - | $3.06 M(-19.4%) |
| Dec 2017 | $3.80 M(-26.2%) | $3.80 M(+64.8%) |
| Sep 2017 | - | $2.31 M(-40.1%) |
| Jun 2017 | - | $3.85 M(-9.5%) |
| Mar 2017 | - | $4.25 M(-17.4%) |
| Dec 2016 | $5.15 M(+227.4%) | $5.15 M(+16.8%) |
| Sep 2016 | - | $4.41 M(+20.8%) |
| Jun 2016 | - | $3.65 M(-20.0%) |
| Mar 2016 | - | $4.56 M(+189.9%) |
| Dec 2015 | $1.57 M(+85.1%) | $1.57 M(-36.3%) |
| Sep 2015 | - | $2.47 M(+28.3%) |
| Jun 2015 | - | $1.93 M(-22.1%) |
| Mar 2015 | - | $2.47 M(+190.6%) |
| Dec 2014 | $850.00 K(-62.6%) | $850.00 K(-27.1%) |
| Sep 2014 | - | $1.17 M(-31.4%) |
| Jun 2014 | - | $1.70 M(-24.1%) |
| Mar 2014 | - | $2.24 M(-1.4%) |
| Dec 2013 | $2.27 M(-15.1%) | $2.27 M(-22.7%) |
| Sep 2013 | - | $2.94 M(+20.3%) |
| Jun 2013 | - | $2.44 M(+5.2%) |
| Mar 2013 | - | $2.32 M(-13.2%) |
| Dec 2012 | $2.67 M(+242.1%) | $2.67 M(+68.7%) |
| Sep 2012 | - | $1.59 M(+53.3%) |
| Jun 2012 | - | $1.03 M(-34.2%) |
| Mar 2012 | - | $1.57 M(+101.0%) |
| Dec 2011 | $781.50 K(-44.1%) | $781.50 K(+38.7%) |
| Sep 2011 | - | $563.50 K(-36.8%) |
| Jun 2011 | - | $891.20 K(+0.4%) |
| Mar 2011 | - | $887.40 K(-36.6%) |
| Dec 2010 | $1.40 M(+43.4%) | $1.40 M(-19.8%) |
| Jun 2010 | - | $1.74 M(+55.1%) |
| Mar 2010 | - | $1.13 M(+15.3%) |
| Dec 2009 | $975.50 K(-18.7%) | $975.50 K(-13.8%) |
| Sep 2009 | - | $1.13 M(+3.5%) |
| Jun 2009 | - | $1.09 M(-14.3%) |
| Mar 2009 | - | $1.28 M(+6.3%) |
| Dec 2008 | $1.20 M(+0.6%) | $1.20 M(+27.6%) |
| Sep 2008 | - | $940.70 K(-26.1%) |
| Jun 2008 | - | $1.27 M(-26.9%) |
| Mar 2008 | - | $1.74 M(+46.0%) |
| Dec 2007 | $1.19 M(-11.6%) | $1.19 M(-15.9%) |
| Sep 2007 | - | $1.42 M(+0.6%) |
| Jun 2007 | - | $1.41 M(-17.0%) |
| Mar 2007 | - | $1.70 M(+25.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $1.35 M(+12.4%) | $1.35 M(+9.1%) |
| Sep 2006 | - | $1.24 M(-7.2%) |
| Jun 2006 | - | $1.33 M(-26.3%) |
| Mar 2006 | - | $1.81 M(+50.6%) |
| Dec 2005 | $1.20 M(-29.4%) | $1.20 M(-7.9%) |
| Sep 2005 | - | $1.30 M(-2.4%) |
| Jun 2005 | - | $1.34 M(-31.9%) |
| Mar 2005 | - | $1.96 M(+15.2%) |
| Dec 2004 | $1.70 M(-49.3%) | $1.70 M(+22.1%) |
| Sep 2004 | - | $1.39 M(-10.2%) |
| Jun 2004 | - | $1.55 M(-22.3%) |
| Mar 2004 | - | $1.99 M(-40.6%) |
| Dec 2003 | $3.36 M(+42.5%) | $3.36 M(+21.0%) |
| Sep 2003 | - | $2.77 M(-30.3%) |
| Jun 2003 | - | $3.98 M(+2.7%) |
| Mar 2003 | - | $3.88 M(+64.6%) |
| Dec 2002 | $2.36 M(+25.1%) | $2.36 M(+78.0%) |
| Sep 2002 | - | $1.32 M(+1.8%) |
| Jun 2002 | - | $1.30 M(-34.0%) |
| Mar 2002 | - | $1.97 M(+4.6%) |
| Dec 2001 | $1.88 M(-0.6%) | $1.88 M(+37.5%) |
| Sep 2001 | - | $1.37 M(-7.2%) |
| Jun 2001 | - | $1.48 M(-23.1%) |
| Mar 2001 | - | $1.92 M(+1.3%) |
| Dec 2000 | $1.90 M(+3.9%) | $1.90 M(-2.3%) |
| Sep 2000 | - | $1.94 M(+8.7%) |
| Jun 2000 | - | $1.79 M(-15.1%) |
| Mar 2000 | - | $2.10 M(+15.3%) |
| Dec 1999 | $1.82 M(+21.6%) | $1.82 M(+1.3%) |
| Sep 1999 | - | $1.80 M(+5.9%) |
| Jun 1999 | - | $1.70 M(+6.3%) |
| Mar 1999 | - | $1.60 M(+6.7%) |
| Dec 1998 | $1.50 M(+50.0%) | $1.50 M(+15.4%) |
| Sep 1998 | - | $1.30 M(-7.1%) |
| Jun 1998 | - | $1.40 M(0.0%) |
| Mar 1998 | - | $1.40 M(+40.0%) |
| Dec 1997 | $1.00 M(0.0%) | $1.00 M(+25.0%) |
| Sep 1997 | - | $800.00 K(-11.1%) |
| Jun 1997 | - | $900.00 K(-18.2%) |
| Mar 1997 | - | $1.10 M(+10.0%) |
| Dec 1996 | $1.00 M(-37.5%) | $1.00 M(+25.0%) |
| Sep 1996 | - | $800.00 K(-20.0%) |
| Jun 1996 | - | $1.00 M(-9.1%) |
| Mar 1996 | - | $1.10 M(-31.3%) |
| Dec 1995 | $1.60 M(+23.1%) | $1.60 M(+60.0%) |
| Sep 1995 | - | $1.00 M(+25.0%) |
| Jun 1995 | - | $800.00 K(-11.1%) |
| Mar 1995 | - | $900.00 K(-30.8%) |
| Dec 1994 | $1.30 M(-13.3%) | $1.30 M(-7.1%) |
| Sep 1994 | - | $1.40 M(-17.6%) |
| Jun 1994 | - | $1.70 M(-5.6%) |
| Mar 1994 | - | $1.80 M(+20.0%) |
| Dec 1993 | $1.50 M(+36.4%) | $1.50 M(+7.1%) |
| Sep 1993 | - | $1.40 M(+7.7%) |
| Jun 1993 | - | $1.30 M(+8.3%) |
| Mar 1993 | - | $1.20 M(+9.1%) |
| Dec 1992 | $1.10 M(+37.5%) | $1.10 M(0.0%) |
| Sep 1992 | - | $1.10 M(+57.1%) |
| Jun 1992 | - | $700.00 K(+75.0%) |
| Mar 1992 | - | $400.00 K(-50.0%) |
| Dec 1991 | $800.00 K(-11.1%) | $800.00 K(-20.0%) |
| Sep 1991 | - | $1.00 M(+66.7%) |
| Jun 1991 | - | $600.00 K(0.0%) |
| Mar 1991 | - | $600.00 K(-33.3%) |
| Dec 1990 | $900.00 K(+50.0%) | $900.00 K(+125.0%) |
| Sep 1990 | - | $400.00 K(-50.0%) |
| Jun 1990 | - | $800.00 K(+166.7%) |
| Mar 1990 | - | $300.00 K(-50.0%) |
| Dec 1989 | $600.00 K | $600.00 K(+50.0%) |
| Sep 1989 | - | $400.00 K(-87.1%) |
| Jun 1989 | - | $3.10 M |
FAQ
- What is ImmuCell annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ImmuCell?
- What is ImmuCell annual cash & cash equivalents year-on-year change?
- What is ImmuCell quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ImmuCell?
- What is ImmuCell quarterly cash and cash equivalents year-on-year change?
What is ImmuCell annual cash & cash equivalents?
The current annual cash & cash equivalents of ICCC is $979.00 K
What is the all time high annual cash & cash equivalents for ImmuCell?
ImmuCell all-time high annual cash & cash equivalents is $10.19 M
What is ImmuCell annual cash & cash equivalents year-on-year change?
Over the past year, ICCC annual cash & cash equivalents has changed by -$4.81 M (-83.10%)
What is ImmuCell quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ICCC is $3.81 M
What is the all time high quarterly cash and cash equivalents for ImmuCell?
ImmuCell all-time high quarterly cash and cash equivalents is $11.82 M
What is ImmuCell quarterly cash and cash equivalents year-on-year change?
Over the past year, ICCC quarterly cash and cash equivalents has changed by +$2.85 M (+296.61%)